Rchr
J-GLOBAL ID:202401002473935390
Update date: Aug. 05, 2024
Hashimoto Teppei
Hashimoto Teppei
Research theme for competitive and other funds (2):
- 2022 - 2026 好酸球性多発血管炎性肉芽腫症におけるcfDNAの好酸球からの放出と炎症への関与
- 2014 - 2016 Role of the clock genes in rheumatoid arthritis
Papers (15):
-
Kazuteru Noguchi, Tetsuya Furukawa, Yoshiki Tatsumi, Shuhei Kasama, Takahiro Yoshikawa, Teppei Hashimoto, Naoto Azuma, Seiichi Hirota, Takashi Kimura, Kiyoshi Matsui. Involvement of YKL-40-positive macrophages commonly identified in polymyositis and dermatomyositis in the pathogenesis of myositis: a retrospective study. Immunological medicine. 2024. 47. 1. 37-44
-
Takahiro Yoshikawa, Tetsuya Furukawa, Teppei Hashimoto, Naoto Azuma, Kiyoshi Matsui. Association of Baseline Serum Soluble Tumour Necrosis Factor Receptor Levels with the Response of Rheumatoid Arthritis to Janus Kinase Inhibitor Therapy. International journal of rheumatology. 2024. 2024. 2898586-2898586
-
Teppei Hashimoto, Kohsuke Yoshida, Yuichi Yokoyama, Naonori Hashimoto, Kenta Kaneshiro, Takahiro Yoshikawa, Koji Tateishi, Yasuhiro Terashima, Kiyoshi Matsui, Akira Hashiramoto. Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis. Clinical and experimental immunology. 2023. 213. 2. 209-220
-
Masao Tamura, Kuniyoshi Shimakura, Yukihiro Kobayashi, Takahiro Yoshikawa, Teppei Hashimoto, Naoto Azuma, Kiyoshi Matsui. [COMPONENT ANALYSIS OF THREE ANISAKIASIS ALLERGY CASES IN OUR DEPARTMENT]. Arerugi = [Allergy]. 2023. 72. 9. 1154-1157
-
Kazuyuki Tsuboi, Kazuteru Noguchi, Masayasu Kitano, Tetsuya Furukawa, Teppei Hashimoto, Naoto Azuma, Kiyoshi Matsui. Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis. Immunological medicine. 2022. 45. 4. 238-243
more...
MISC (7):
-
Suzuki Emu, Azuma Naoto, Tamura Masao, Morimoto Mai, Yoshikawa Takahiro, Yokoyama Yuichi, Furukawa Tetsuya, Ogita Chie, Hashimoto Teppei, Matsui Kiyoshi, et al. Survey on switching from a subcutaneous syringe to an autoinjection pen for the administration of adalimumab(Humira®)in patients with rheumatic diseases. Clinical Rheumatology and Related Research. 2022. 34. 3. 204-212
-
橋本 哲平. 好酸球性多発血管炎性肉芽腫症における好酸球細胞外トラップと免疫血栓症. 兵庫医科大学雑誌. 2022. 47. 49-53
-
Noguchi Kazuteru, Hashimoto Teppei, Ogita Chie, Azuma Naoto, Matsui Kiyoshi, Tokuhara Yusuke, Kasama Shuhei, Yoshikawa Hiroo, Kitano Masayasu. The patient with Necrotic myopathy who exhibited head down condition as the chief symptom. Clinical Rheumatology and Related Research. 2021. 33. 1. 55-61
-
橋本 哲平, 佐野 統. インフリキシマブ-特集 内科疾患における生物学的製剤の使い分け ; 生物学的製剤を極める. Modern physician = モダンフィジシャン. 2018. 38. 9. 935-937
-
Kohjin Suzuki, Kohsuke Yoshida, Teppei Hashimoto, Kenta Kaneshiro, Ayako Nakai, Naonori Hashimoto, Yoshiko Kawasaki, Nao Shibanuma, Natsuko Nakagawa, Yoshitada Sakai, et al. A Novel Pharmacological Action of MTX on RA Fibroblast-like Synoviocytes Via Circadian Clock Genes. ARTHRITIS & RHEUMATOLOGY. 2016. 68
more...
Return to Previous Page